The Nitazene Control Act would permanently classify nitazenes—a family of powerful synthetic opioids that are sometimes stronger than fentanyl—as Schedule I controlled substances under federal law. Currently, the Drug Enforcement Administration has only temporarily scheduled individual nitazene compounds, but this bill would create a permanent, class-wide ban on all 2-benzylbenzimidazole opioids and their chemical variants to prevent manufacturers from creating new designer drugs to skirt existing laws. The legislation affects drug manufacturers, traffickers, and law enforcement agencies responsible for combating illicit drug supply, while also establishing research pathways for legitimate scientific study under the HALT Fentanyl Act. Congress found that nitazenes have increasingly appeared in the illicit drug supply and contributed to overdose deaths, making permanent scheduling necessary to preemptively address new analogs and streamline enforcement efforts. The bill contains no specific funding allocations or implementation timelines beyond taking effect upon enactment.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.